320 related articles for article (PubMed ID: 32719975)
1. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
Hauer L; Perneczky J; Sellner J
J Neurol; 2021 Nov; 268(11):4066-4077. PubMed ID: 32719975
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis and migraine: Links, management and implications.
Mrabet S; Wafa M; Giovannoni G
Mult Scler Relat Disord; 2022 Dec; 68():104152. PubMed ID: 36058193
[TBL] [Abstract][Full Text] [Related]
3. Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!
Šťastná D; Seňavová J; Andělová M; Menkyová I; Pšenička O; Horáková D
Vnitr Lek; 2023; 69(5):294-298. PubMed ID: 37827827
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy).
Bezzini D; Gualdani E; Razzanelli M; Battaglia MA; Cortese R; Francesconi P; Ulivelli M
Neurol Sci; 2022 Nov; 43(11):6407-6414. PubMed ID: 35978257
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity in multiple sclerosis: implications for patient care.
Marrie RA
Nat Rev Neurol; 2017 Jun; 13(6):375-382. PubMed ID: 28303911
[TBL] [Abstract][Full Text] [Related]
6. Vascular comorbidities in the onset and progression of multiple sclerosis.
Tettey P; Simpson S; Taylor BV; van der Mei IA
J Neurol Sci; 2014 Dec; 347(1-2):23-33. PubMed ID: 25454639
[TBL] [Abstract][Full Text] [Related]
7. Perceived health- related quality of life in persons with multiple sclerosis with and without a vascular comorbidity.
Neto LO; Ruiz JA; Gromisch ES
Qual Life Res; 2024 Feb; 33(2):573-581. PubMed ID: 37966685
[TBL] [Abstract][Full Text] [Related]
8. The economic impact of comorbidity in multiple sclerosis.
Ponzio M; Monti MC; Mallucci G; Borrelli P; Fusco S; Tacchino A; Brichetto G; Tronconi L; Montomoli C; Bergamaschi R
Neurol Sci; 2023 Mar; 44(3):999-1008. PubMed ID: 36441342
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities at multiple sclerosis diagnosis.
Fromont A; Binquet C; Rollot F; Despalins R; Weill A; Clerc L; Bonithon-Kopp C; Moreau T
J Neurol; 2013 Oct; 260(10):2629-37. PubMed ID: 23907437
[TBL] [Abstract][Full Text] [Related]
10. Etiology, effects and management of comorbidities in multiple sclerosis: recent advances.
Marrie RA; Fisk JD; Fitzgerald K; Kowalec K; Maxwell C; Rotstein D; Salter A; Tremlett H
Front Immunol; 2023; 14():1197195. PubMed ID: 37325663
[TBL] [Abstract][Full Text] [Related]
11. Multiple Sclerosis and Autoimmune Comorbidities.
Nociti V; Romozzi M
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579555
[TBL] [Abstract][Full Text] [Related]
12. Restless legs syndrome in people with multiple sclerosis: An updated systematic review and meta-analyses.
Ozdogar AT; Kalron A
Mult Scler Relat Disord; 2021 Nov; 56():103275. PubMed ID: 34592631
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity in multiple sclerosis: Past, present and future.
Marrie RA
Clin Invest Med; 2019 Mar; 42(1):E5-E12. PubMed ID: 30904030
[TBL] [Abstract][Full Text] [Related]
14. Blood lactate concentrations during rest and exercise in people with Multiple Sclerosis: A systematic review and meta-analysis.
Cerexhe L; Easton C; Macdonald E; Renfrew L; Sculthorpe N
Mult Scler Relat Disord; 2022 Jan; 57():103454. PubMed ID: 34915317
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.
Maric GD; Pekmezovic TD; Mesaros ST; Tamas OS; Ivanovic JB; Martinovic VN; Andabaka MM; Jovanovic AL; Veselinovic ND; Kisic-Tepavcevic DB; Drulovic JS
Neurol Sci; 2021 May; 42(5):1887-1893. PubMed ID: 32964347
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.
Ciampi E; Uribe-San-Martin R; Soler B; Molnar K; Reyes D; Keller K; Carcamo C
Mult Scler Relat Disord; 2020 Nov; 46():102565. PubMed ID: 33039942
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of restless legs syndrome in multiple sclerosis.
Manconi M; Fabbrini M; Bonanni E; Filippi M; Rocca M; Murri L; Ferini-Strambi L
Eur J Neurol; 2007 May; 14(5):534-9. PubMed ID: 17437613
[TBL] [Abstract][Full Text] [Related]
18. Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis.
Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; van der Mei I
J Neurol; 2021 Feb; 268(2):602-612. PubMed ID: 32880720
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review.
Oliva Ramirez A; Keenan A; Kalau O; Worthington E; Cohen L; Singh S
BMC Neurol; 2021 Dec; 21(1):468. PubMed ID: 34856949
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity in Multiple Sclerosis.
Magyari M; Sorensen PS
Front Neurol; 2020; 11():851. PubMed ID: 32973654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
